Keywords: Hospira, Financial results, Third-quarter 2012, Injectable drugs

Hospira returns to profit, with EPS beating expectations

Article | 08 November 2012

Print This

USA-based Hospira (NYSE: HSP), a global leader in injectable drugs and infusion technologies, reported results for the third quarter of 2012, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in